The difference your support of Garvan makes
Medical research - saving lives
Medical research has already made a profound difference to our lives. For example, over the past 20 years we have seen the survival rate of many common cancers increase by up to 30%.
A gift to Garvan allows our scientists to continue contributing to knowledge which will ultimately lead to earlier diagnosis, better disease management, new therapies and prevention or cure of a range of disease. Read more about the work you support.
Back to top
Why Garvan needs your help
Your donations to the Garvan, through Garvan Research Foundation, are vital to ensuring our work can continue. This is because grants through the major Australian funding body the National Health and Medical Research Council (NHMRC) do not cover the full costs of research.
For every $1 received through these grants, Garvan requires another $0.70 to do our work.
This is to cover the:
- Establishment and maintenance costs of shared state of the art scientific facilities
- Funding of novel projects which are too early-stage to be eligible for grants
- Costs of the high tech IT needed to run complex scientific analyses and databases
- Purchase of equipment vital to our work such as gene chip machines and microscopes
Without your support Garvan scientists would not be able to do their work.
Back to top
Why give to Garvan?
- Garvan is a world-renowned institute with a history of significant breakthroughs
- Garvan attracts the finest minds – Professor John Shine, our Executive Director, is internationally recognised as a leader in the field and was the first scientist to clone a human hormone gene
- Garvan scientists collaborate both internationally and amongst themselves across a range of diseases. A breakthrough in one area often leads to a discovery in another.
- Garvan is recognised for excellence in medical research. We have a success rate in funding from the NHMRC well above the national average
- In 2009 we published 176 papers with an average impact factor of 9.2 for the top 80% - well above the international benchmark. Each paper represents a new piece of knowledge contributed to the global understanding of disease.
- Garvan's accounts are transparent and externally audited by PriceWaterhouse Coopers and Annual Reports are available on this site.
- The Garvan Research Foundation's cost to income ratio for 2009 was 9% - well below industry standards.
Back to top